TABLE 1.
PICOS inclusion and exclusion criteria of studies in the systematic review and meta-analysis of the effects of Asp/Ace-K blends on human appetite, blood glucose, and incretins1
| PICOS | Inclusion | Exclusion |
|---|---|---|
| Population | • Male and females, humans• Normal weight, overweight, obese2• >18 y old• Type 2 diabetes mellitus | • Animals/cells• <18 y old• Other diagnosed chronic diseases |
| Intervention |
Foods/beverages sweetened with
|
Foods/beverages sweetened without
|
| Comparisons |
Foods/beverages with
|
|
| Outcomes | • Energy intake• Subjective appetite• Blood glucose• GLP-1• GIP | |
| Study design | • Randomized controlled trials• Laboratory/free-living• Acute (<1 d)• Chronic (>1 d) | • Nonrandomized controlled trials• Observational/cohort studies |
Ace-K, acesulfame-K; Asp, aspartame; GIP, glucose-dependent insulinotropic peptide; GLP-1, glucagon-like peptide 1; NNS, nonnutritive sweetener.
As defined by the WHO guidelines (58).